|
1
|
Kasabach HH and Merritt KK: Capillary
hemangioma with extensive purpura: report of a case. Am J Dis
Child. 59:1063–1070. 1940. View Article : Google Scholar
|
|
2
|
Enjolras O, Mulliken JB, Wassef M, Frieden
IJ, Rieu PN, Burrows PE, Salhi A, Léauté-Labreze C and Kozakewich
HP: Residual lesions after Kasabach-Merritt phenomenon in 41
patients. J Am Acad Dermatol. 42:225–235. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Le Nouail P, Viseux V and Enjolras O:
Groupe de Recherche Clinique en Dermatologie Pédiatrique:
Kasabach–Merritt phenomenon. Ann Dermatol Venereol. 134:580–586.
2007.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
4
|
O'Rafferty C, O'Regan GM, Irvine AD and
Smith OP: Recent advances in the pathobiology and management of
Kasabach-Merritt phenomenon. Br J Haematol. 171:38–51. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ferrandiz-Pulido C, Mollet J, Sabado C,
Ferrer B and Garcia-Patos V: Tufted angioma associated with
Kasabach-Merritt phenomenon: A therapeutic challenge. Act Derm
Venereol. 90:535–537. 2010.
|
|
6
|
Chu CY, Hsiao CH and Chiu HC:
Transformation between Kaposiform hemangioendothelioma and tufted
angioma. Dermatology. 206:334–337. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakagawa K: Case report of angioblastoma
of the skin. Jpn J Dermatol. 59:92–94. 1949.
|
|
8
|
Jones EW and Orkin M: Tufted angioma
(angioblastoma). A benign progressive angioma, not to be confused
with Kaposi's sarcoma or low-grade angiosarcoma. J Am Acad
Dermatol. 20:214–225. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sadeghpour M, Antaya RJ, Lazova R and Ko
CJ: Dilated lymphatic vessels in tufted angioma: A potential source
of diagnostic confusion. Am J Dermatopathol. 34:400–403. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hall GW: Kasabach-Merritt syndrome:
Pathogenesis and management. Br J Haematol. 112:851–862. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim T, Roh MR, Cho S and Chung KY:
Kasabach-merritt syndrome arising from tufted angioma successfully
treated with systemic corticosteroid. Ann Dermatol. 22:426–430.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fahrtash F, McCahon E and Arbuckle S:
Successful treatment of kaposiform hemangioendothelioma and tufted
angioma with vincristine. J Pediatr Hematol Oncol. 32:506–510.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hermans DJ, van Beynum IM, van der Vijver
RJ, Kool LJ, de Blaauw I and van der Vleuten CJ: Kaposiform
hemangioendothelioma with Kasabach-Merritt syndrome: A new
indication for propranolol treatment. J Pediatr Hematol Oncol.
33:e171–e173. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mahendran R, White SI, Clark AH and
Sheehan-Dare RA: Response of childhood tufted angioma to the
pulsed-dye laser. J Am Acad Dermatol. 47:620–622. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hammill AM, Wentzel M, Gupta A, Nelson S,
Lucky A, Elluru R, Dasgupta R, Azizkhan RG and Adams DM: Sirolimus
for the treatment of complicated vascular anomalies in children.
Pediatr Blood Cancer. 57:1018–1024. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rodriguez V, Lee A, Witman PM and Anderson
PA: Kasabach-merritt phenomenon: Case series and retrospective
review of the mayo clinic experience. J Pediatr Hematol Oncol.
31:522–526. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Z, Li K, Dong K, Xiao X and Zheng S:
Variable response to propranolol treatment of kaposiform
hemangioendothelioma, tufted angioma and Kasabach-Merritt
phenomenon. Pediatr Blood Cancer. 61:1518–1519. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chiu YE, Drolet BA, Blei F, Carcao M,
Fangusaro J, Kelly ME, Krol A, Lofgren S, Mancini AJ, Metry DW, et
al: Variable response to propranolol treatment of kaposiform
hemangioendothelioma, tufted angioma and Kasabach-Merritt
phenomenon. Pediatric Blood Cancer. 59:934–938. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi JW, Na JI, Hong JS, Kwon SH, Byun SY,
Cho KH, Youn SW, Choi HS, Park KD and Park KC: Intractable tufted
angioma associated with kasabach-merritt syndrome. Ann Dermatol.
25:129–130. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brunton L, Lazo J and Paker K: Goodman
& Gliman's The Pharmacological Basis of Therapeutics. 11th.
McGraw-Hill; New York: 2005
|
|
21
|
Haisley-Royster C, Enjolras O, Frieden IJ,
Garzon M, Lee M, Oranje A, de Laat PC, Madern GC, Gonzalez F,
Frangoul H, et al: Kasabach-merritt phenomenon: A retrospective
study of treatment with vincristine. J Pediatr Hematol Oncol.
24:459–462. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Drolet BA, Trenor CC III, Brandão LR, Chiu
YE, Chun RH, Dasgupta R, Garzon MC, Hammill AM, Johnson CM, Tlougan
B, et al: Consensus-derived practice standards plan for complicated
Kaposiform hemangioendothelioma. J Pediatr. 163:285–291. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hauer J, Graubner U, Konstantopoulous N,
Schmidt S, Pfluger T and Schmid I: Effective treatment of
kaposiform hemangioendotheliomas associated with Kasabach-Merritt
phenomenon using four-drug regimen. Pediatr Blood Cancer.
49:852–854. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
de la Hunt MN: Kasabach-Merritt syndrome:
Dangers of interferon and successful treatment with pentoxifylline.
J Pediatr Surg. 41:e29–e31. 2006. View Article : Google Scholar : PubMed/NCBI
|
